{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:16:49Z","timestamp":1790997409780,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81900266"],"award-info":[{"award-number":["81900266"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00011-024-01875-8","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T08:01:50Z","timestamp":1713600110000},"page":"929-943","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor necrosis factor receptor-associated factor 5 protects against intimal hyperplasia by regulation of macrophage polarization via directly targeting PPAR\u03b3"],"prefix":"10.1007","volume":"73","author":[{"given":"Wen-Lin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-ping","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Huan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Qiong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,20]]},"reference":[{"key":"1875_CR1","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1056\/NEJMe1610485","volume":"375","author":"ER Bates","year":"2016","unstructured":"Bates ER. Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med. 2016;375:2605.","journal-title":"N Engl J Med"},{"key":"1875_CR2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0140-6736(17)31927-X","volume":"390","author":"RA Byrne","year":"2017","unstructured":"Byrne RA, Stone GW, Ormiston J, Kastrati A. Coronary balloon angioplasty, stents, and scaffolds. Lancet. 2017;390:781\u201392.","journal-title":"Lancet"},{"key":"1875_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0140-6736(17)31957-8","volume":"390","author":"GS Mintz","year":"2017","unstructured":"Mintz GS, Guagliumi G. Intravascular imaging in coronary artery disease. Lancet. 2017;390:793\u2013809.","journal-title":"Lancet"},{"key":"1875_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0140-6736(17)32238-9","volume":"390","author":"L The","year":"2017","unstructured":"The L. 40 years of percutaneous coronary intervention: Where next? Lancet. 2017;390:715.","journal-title":"Lancet"},{"key":"1875_CR5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/0267659112452316","volume":"27","author":"B Mills","year":"2012","unstructured":"Mills B, Robb T, Larson DF. Intimal hyperplasia: slow but deadly. Perfusion. 2012;27:520\u20138.","journal-title":"Perfusion"},{"key":"1875_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A. Macrophage plasticity and polarization: In vivo veritas. J Clin Invest. 2012;122:787\u201395.","journal-title":"J Clin Invest"},{"key":"1875_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.imbio.2008.11.009","volume":"214","author":"A Varin","year":"2009","unstructured":"Varin A, Gordon S. Alternative activation of macrophages: Immune function and cellular biology. Immunobiology. 2009;214:630\u201341.","journal-title":"Immunobiology"},{"key":"1875_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1161\/CIRCRESAHA.116.309194","volume":"119","author":"M Nahrendorf","year":"2016","unstructured":"Nahrendorf M, Swirski FK. Abandoning m1\/m2 for a network model of macrophage function. Circ Res. 2016;119:414\u20137.","journal-title":"Circ Res"},{"key":"1875_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","volume":"79","author":"PJ Murray","year":"2017","unstructured":"Murray PJ. Macrophage polarization. Annu Rev Physiol. 2017;79:541\u201366.","journal-title":"Annu Rev Physiol"},{"key":"1875_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1006\/excr.1999.4733","volume":"254","author":"J Inoue","year":"2000","unstructured":"Inoue J, Ishida T, Tsukamoto N, Kobayashi N, Naito A, Azuma S, Yamamoto T. Tumor necrosis factor receptor-associated factor (traf) family: adapter proteins that mediate cytokine signaling. Exp Cell Res. 2000;254:14\u201324.","journal-title":"Exp Cell Res"},{"key":"1875_CR11","doi-asserted-by":"publisher","first-page":"6482","DOI":"10.1038\/sj.onc.1204788","volume":"20","author":"JR Bradley","year":"2001","unstructured":"Bradley JR, Pober JS. Tumor necrosis factor receptor-associated factors (trafs). Oncogene. 2001;20:6482\u201391.","journal-title":"Oncogene"},{"key":"1875_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cardiores.2004.06.014","volume":"64","author":"T Miyahara","year":"2004","unstructured":"Miyahara T, Koyama H, Miyata T, Shigematsu H, Inoue J, Takato T, Nagawa H. Inflammatory signaling pathway containing traf6 contributes to neointimal formation via diverse mechanisms. Cardiovasc Res. 2004;64:154\u201364.","journal-title":"Cardiovasc Res"},{"key":"1875_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jvs.2005.11.010","volume":"43","author":"T Miyahara","year":"2006","unstructured":"Miyahara T, Koyama H, Miyata T, Shigematsu H, Inoue J, Takato T, Nagawa H. Inflammatory responses involving tumor necrosis factor receptor-associated factor 6 contribute to in-stent lesion formation in a stent implantation model of rabbit carotid artery. J Vasc Surg. 2006;43:592\u2013600.","journal-title":"J Vasc Surg"},{"key":"1875_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1161\/CIRCRESAHA.110.219295","volume":"107","author":"A Missiou","year":"2010","unstructured":"Missiou A, Rudolf P, Stachon P, Wolf D, Varo N, Aichele P, Colberg C, Hoppe N, Ernst S, Munkel C, Walter C, Sommer B, Hilgendorf I, Nakano H, Bode C, Zirlik A. Traf5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation. Circ Res. 2010;107:757\u201366.","journal-title":"Circ Res"},{"key":"1875_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-065X.2011.01055.x","volume":"244","author":"JM Hildebrand","year":"2011","unstructured":"Hildebrand JM, Yi Z, Buchta CM, Poovassery J, Stunz LL, Bishop GA. Roles of tumor necrosis factor receptor associated factor 3 (traf3) and traf5 in immune cell functions. Immunol Rev. 2011;244:55\u201374.","journal-title":"Immunol Rev"},{"key":"1875_CR16","doi-asserted-by":"publisher","first-page":"10592","DOI":"10.1038\/ncomms10592","volume":"7","author":"PX Wang","year":"2016","unstructured":"Wang PX, Zhang XJ, Luo P, Jiang X, Zhang P, Guo J, Zhao GN, Zhu X, Zhang Y, Yang S, Li H. Hepatocyte traf3 promotes liver steatosis and systemic insulin resistance through targeting tak1-dependent signalling. Nat Commun. 2016;7:10592.","journal-title":"Nat Commun"},{"key":"1875_CR17","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1161\/CIRCULATIONAHA.109.895037","volume":"121","author":"A Missiou","year":"2010","unstructured":"Missiou A, Kostlin N, Varo N, Rudolf P, Aichele P, Ernst S, Munkel C, Walter C, Stachon P, Sommer B, Pfeifer D, Zirlik K, MacFarlane L, Wolf D, Tsitsikov E, Bode C, Libby P, Zirlik A. Tumor necrosis factor receptor-associated factor 1 (traf1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall. Circulation. 2010;121:2033\u201344.","journal-title":"Circulation"},{"key":"1875_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cellsig.2013.12.009","volume":"26","author":"G Ruspi","year":"2014","unstructured":"Ruspi G, Schmidt EM, McCann F, Feldmann M, Williams RO, Stoop AA, Dean JL. Tnfr2 increases the sensitivity of ligand-induced activation of the p38 mapk and nf-kappab pathways and signals traf2 protein degradation in macrophages. Cell Signal. 2014;26:683\u201390.","journal-title":"Cell Signal"},{"key":"1875_CR19","doi-asserted-by":"publisher","first-page":"C1161","DOI":"10.1152\/ajpcell.00264.2019","volume":"317","author":"A Das","year":"2019","unstructured":"Das A, Sudhahar V, Ushio-Fukai M, Fukai T. Novel interaction of antioxidant-1 with traf4: role in inflammatory responses in endothelial cells. Am J Physiol Cell Physiol. 2019;317:C1161\u201371.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1875_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/jnc.12207","volume":"126","author":"L Wang","year":"2013","unstructured":"Wang L, Lu Y, Guan H, Jiang D, Guan Y, Zhang X, Nakano H, Zhou Y, Zhang Y, Yang L, Li H. Tumor necrosis factor receptor-associated factor 5 is an essential mediator of ischemic brain infarction. J Neurochem. 2013;126:400\u201314.","journal-title":"J Neurochem"},{"key":"1875_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jhep.2016.03.006","volume":"65","author":"L Gao","year":"2016","unstructured":"Gao L, Wang PX, Zhang Y, Yu CJ, Ji Y, Wang X, Zhang P, Jiang X, Jin H, Huang Z, Zhang ZR, Li H. Tumor necrosis factor receptor-associated factor 5 (traf5) acts as an essential negative regulator of hepatic steatosis. J Hepatol. 2016;65:125\u201336.","journal-title":"J Hepatol"},{"key":"1875_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jcb.24669","volume":"115","author":"Z Bian","year":"2014","unstructured":"Bian Z, Dai J, Hiroyasu N, Guan H, Yuan Y, Gan L, Zhou H, Zong J, Zhang Y, Li F, Yan L, Shen D, Li H, Tang Q. Disruption of tumor necrosis factor receptor associated factor 5 exacerbates pressure overload cardiac hypertrophy and fibrosis. J Cell Biochem. 2014;115:349\u201358.","journal-title":"J Cell Biochem"},{"key":"1875_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173092","volume":"878","author":"W Xu","year":"2020","unstructured":"Xu W, Zhang L, Ma S, Zhang Y, Cai Z, Zhang K, Jin D. Traf5 protects against myocardial ischemia reperfusion injury via akt signaling. Eur J Pharmacol. 2020;878: 173092.","journal-title":"Eur J Pharmacol"},{"key":"1875_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/187152911795945169","volume":"11","author":"ER Ob","year":"2011","unstructured":"Ob ER, Ma X, Simard T, Pourdjabbar A, Hibbert B. Pathogenesis of neointima formation following vascular injury. Cardiovasc Hematol Disord Drug Targets. 2011;11:30\u20139.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"Suppl 1","key":"1875_CR25","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2310\/6670.2008.00089","volume":"17","author":"EM Rzucidlo","year":"2009","unstructured":"Rzucidlo EM. Signaling pathways regulating vascular smooth muscle cell differentiation. Vascular. 2009;17(Suppl 1):S15-20.","journal-title":"Vascular"},{"key":"1875_CR26","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1161\/ATVBAHA.111.226670","volume":"31","author":"BN Davis-Dusenbery","year":"2011","unstructured":"Davis-Dusenbery BN, Wu C, Hata A. Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler Thromb Vasc Biol. 2011;31:2370\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1875_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/CIRCINTERVENTIONS.110.957332","volume":"4","author":"SO Marx","year":"2011","unstructured":"Marx SO, Totary-Jain H, Marks AR. Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv. 2011;4:104\u201311.","journal-title":"Circ Cardiovasc Interv"},{"key":"1875_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1146\/annurev-physiol-012110-142315","volume":"74","author":"MR Alexander","year":"2012","unstructured":"Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol. 2012;74:13\u201340.","journal-title":"Annu Rev Physiol"},{"key":"1875_CR29","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/ATVBAHA.108.180497","volume":"29","author":"A Mantovani","year":"2009","unstructured":"Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol. 2009;29:1419\u201323.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1875_CR30","doi-asserted-by":"publisher","first-page":"36530","DOI":"10.1074\/jbc.M104837200","volume":"276","author":"K Tada","year":"2001","unstructured":"Tada K, Okazaki T, Sakon S, Kobarai T, Kurosawa K, Yamaoka S, Hashimoto H, Mak TW, Yagita H, Okumura K, Yeh WC, Nakano H. Critical roles of traf2 and traf5 in tumor necrosis factor-induced nf-kappa b activation and protection from cell death. J Biol Chem. 2001;276:36530\u20134.","journal-title":"J Biol Chem"},{"key":"1875_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/ni.2863","volume":"15","author":"H Nagashima","year":"2014","unstructured":"Nagashima H, Okuyama Y, Asao A, Kawabe T, Yamaki S, Nakano H, Croft M, Ishii N, So T. The adaptor traf5 limits the differentiation of inflammatory cd4(+) t cells by antagonizing signaling via the receptor for il-6. Nat Immunol. 2014;15:449\u201356.","journal-title":"Nat Immunol"},{"key":"1875_CR32","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.2337\/db12-1327","volume":"62","author":"J Eguchi","year":"2013","unstructured":"Eguchi J, Kong X, Tenta M, Wang X, Kang S, Rosen ED. Interferon regulatory factor 4 regulates obesity-induced inflammation through regulation of adipose tissue macrophage polarization. Diabetes. 2013;62:3394\u2013403.","journal-title":"Diabetes"},{"key":"1875_CR33","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/ni.1920","volume":"11","author":"T Satoh","year":"2010","unstructured":"Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T, Saitoh T, Honma K, Matsuyama T, Yui K, Tsujimura T, Standley DM, Nakanishi K, Nakai K, Akira S. The jmjd3-irf4 axis regulates m2 macrophage polarization and host responses against helminth infection. Nat Immunol. 2010;11:936\u201344.","journal-title":"Nat Immunol"},{"key":"1875_CR34","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nri3088","volume":"11","author":"T Lawrence","year":"2011","unstructured":"Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: Enabling diversity with identity. Nat Rev Immunol. 2011;11:750\u201361.","journal-title":"Nat Rev Immunol"},{"key":"1875_CR35","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nature05894","volume":"447","author":"JI Odegaard","year":"2007","unstructured":"Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW, Chawla A. Macrophage-specific ppargamma controls alternative activation and improves insulin resistance. Nature. 2007;447:1116\u201320.","journal-title":"Nature"},{"key":"1875_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cmet.2007.07.006","volume":"6","author":"IF Charo","year":"2007","unstructured":"Charo IF. Macrophage polarization and insulin resistance: Ppargamma in control. Cell Metab. 2007;6:96\u20138.","journal-title":"Cell Metab"},{"issue":"Suppl 1","key":"1875_CR37","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1038\/sj.ijo.0802910","volume":"29","author":"D Bruemmer","year":"2005","unstructured":"Bruemmer D, Blaschke F, Law RE. New targets for ppargamma in the vessel wall: implications for restenosis. Int J Obes (Lond). 2005;29(Suppl 1):S26-30.","journal-title":"Int J Obes (Lond)"},{"key":"1875_CR38","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/cvr\/cvr238","volume":"92","author":"LL Zhang","year":"2011","unstructured":"Zhang LL, Gao CY, Fang CQ, Wang YJ, Gao D, Yao GE, Xiang J, Wang JZ, Li JC. Ppargamma attenuates intimal hyperplasia by inhibiting tlr4-mediated inflammation in vascular smooth muscle cells. Cardiovasc Res. 2011;92:484\u201393.","journal-title":"Cardiovasc Res"},{"key":"1875_CR39","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1091\/mbc.e11-09-0805","volume":"23","author":"T Tao","year":"2012","unstructured":"Tao T, Cheng C, Ji Y, Xu G, Zhang J, Zhang L, Shen A. Numbl inhibits glioma cell migration and invasion by suppressing traf5-mediated nf-kappab activation. Mol Biol Cell. 2012;23:2635\u201344.","journal-title":"Mol Biol Cell"},{"key":"1875_CR40","first-page":"2928","volume":"11","author":"M Shang","year":"2021","unstructured":"Shang M, Weng L, Wu S, Liu B, Yin X, Wang Z, Mao A. Hp1bp3 promotes tumor growth and metastasis by upregulating mir-23a to target traf5 in esophageal squamous cell carcinoma. Am J Cancer Res. 2021;11:2928\u201343.","journal-title":"Am J Cancer Res"},{"key":"1875_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.imlet.2018.01.010","volume":"196","author":"X Tang","year":"2018","unstructured":"Tang X, Zhang L, Wei W. Roles of trafs in nf-kappab signaling pathways mediated by baff. Immunol Lett. 2018;196:113\u20138.","journal-title":"Immunol Lett"},{"key":"1875_CR42","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.bbrc.2016.02.021","volume":"471","author":"M Li","year":"2016","unstructured":"Li M, Long C, Yang G, Luo Y, Du H. Mir-26b inhibits melanoma cell proliferation and enhances apoptosis by suppressing traf5-mediated mapk activation. Biochem Biophys Res Commun. 2016;471:361\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1875_CR43","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.bbrc.2019.05.002","volume":"514","author":"Z Liang","year":"2019","unstructured":"Liang Z, Li X, Liu S, Li C, Wang X, Xing J. Mir-141-3p inhibits cell proliferation, migration and invasion by targeting traf5 in colorectal cancer. Biochem Biophys Res Commun. 2019;514:699\u2013705.","journal-title":"Biochem Biophys Res Commun"},{"key":"1875_CR44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12935-021-01847-6","volume":"21","author":"G Ding","year":"2021","unstructured":"Ding G, Zeng Y, Yang D, Zhang C, Mao C, Xiao E, Kang Y, Shang J. Silenced lncrna ddx11-as1 or up-regulated microrna-34a-3p inhibits malignant phenotypes of hepatocellular carcinoma cells via suppression of traf5. Cancer Cell Int. 2021;21:179.","journal-title":"Cancer Cell Int"},{"key":"1875_CR45","first-page":"9050","volume":"23","author":"YL Teng","year":"2019","unstructured":"Teng YL, Ren F, Xu H, Song HJ. Overexpression of mirna-410-3p protects hypoxia-induced cardiomyocyte injury via targeting traf5. Eur Rev Med Pharmacol Sci. 2019;23:9050\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1875_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s10020-021-00415-y","volume":"28","author":"F Zhang","year":"2022","unstructured":"Zhang F, Luo BH, Wu QH, Li QL, Yang KD. Lncrna hcg18 upregulates traf4\/traf5 to facilitate proliferation, migration and emt of epithelial ovarian cancer by targeting mir-29a\/b. Mol Med. 2022;28:2.","journal-title":"Mol Med"},{"key":"1875_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s13205-021-02664-4","volume":"11","author":"P Khanal","year":"2021","unstructured":"Khanal P, Duyu T, Patil BM, Dey YN, Pasha I, Kavalapure RS, Chand S, Gurav S. Screening of jak-stat modulators from the antiviral plants of indian traditional system of medicine with the potential to inhibit 2019 novel coronavirus using network pharmacology. 3 Biotech. 2021;11:119.","journal-title":"3 Biotech"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01875-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-024-01875-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01875-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T03:38:16Z","timestamp":1716262696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-024-01875-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1875"],"URL":"https:\/\/doi.org\/10.1007\/s00011-024-01875-8","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,20]]},"assertion":[{"value":"20 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}